Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule

NCT03329001 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

236

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Niraparib Tablet
DRUG: Niraparib Capsule

Sponsor

Tesaro, Inc.